These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 22049545)

  • 1. Texas prepares to fight for stem cells.
    Cyranoski D
    Nature; 2011 Sep; 477(7365):377-8. PubMed ID: 22049545
    [No Abstract]   [Full Text] [Related]  

  • 2. Bioethics: Tighten up Japan's stem-cell practices.
    Ikegaya H
    Nature; 2012 Sep; 489(7414):33. PubMed ID: 22955600
    [No Abstract]   [Full Text] [Related]  

  • 3. Stem cells in Texas: Cowboy culture.
    Cyranoski D
    Nature; 2013 Feb; 494(7436):166-8. PubMed ID: 23407522
    [No Abstract]   [Full Text] [Related]  

  • 4. Stem cells. Texas Medical Board approves rules for controversial treatment.
    Kaiser J
    Science; 2012 Apr; 336(6079):284. PubMed ID: 22517830
    [No Abstract]   [Full Text] [Related]  

  • 5. FDA's claims over stem cells upheld.
    Cyranoski D
    Nature; 2012 Aug; 488(7409):14. PubMed ID: 22859178
    [No Abstract]   [Full Text] [Related]  

  • 6. FDA challenges stem-cell clinic.
    Cyranoski D
    Nature; 2010 Aug; 466(7309):909. PubMed ID: 20725009
    [No Abstract]   [Full Text] [Related]  

  • 7. FDA should stand firm on stem-cell treatments.
    Nature; 2016 Jul; 535(7610):7-8. PubMed ID: 27383946
    [No Abstract]   [Full Text] [Related]  

  • 8. Caution urged in trial of stem cells to treat spinal-cord injury.
    Barde Y
    Nature; 2009 Mar; 458(7234):29. PubMed ID: 19262651
    [No Abstract]   [Full Text] [Related]  

  • 9. Stem-cell therapy takes off in Texas.
    Cyranoski D
    Nature; 2012 Feb; 483(7387):13-4. PubMed ID: 22382952
    [No Abstract]   [Full Text] [Related]  

  • 10. Improving oversight of innovative medical interventions in Texas, USA.
    Levine AD
    Regen Med; 2012 Jul; 7(4):451-3. PubMed ID: 22817618
    [No Abstract]   [Full Text] [Related]  

  • 11. Texas stem cell rules may impede clinical research.
    Arnold C
    Lancet; 2012 May; 379(9828):1776. PubMed ID: 22586718
    [No Abstract]   [Full Text] [Related]  

  • 12. Texas legitimizes path around FDA oversight.
    DeFrancesco L
    Nat Biotechnol; 2012 May; 30(5):379. PubMed ID: 22565948
    [No Abstract]   [Full Text] [Related]  

  • 13. FDA regulation of adult stem cell therapies as used in sports medicine.
    Chirba MA; Sweetapple B; Hannon CP; Anderson JA
    J Knee Surg; 2015 Feb; 28(1):55-62. PubMed ID: 25603042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stem cell science: current ethical and policy issues.
    Mauron A; Jaconi ME
    Clin Pharmacol Ther; 2007 Sep; 82(3):330-3. PubMed ID: 17637783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unknown territory.
    Nature; 2013 Feb; 494(7435):5. PubMed ID: 23393655
    [No Abstract]   [Full Text] [Related]  

  • 16. Letter campaign sought to pressure FDA action on stem cell clinics.
    Dolgin E
    Nat Med; 2014 Aug; 20(8):796-7. PubMed ID: 25100513
    [No Abstract]   [Full Text] [Related]  

  • 17. Regulating autologous adult stem cells: the FDA steps up.
    Lysaght T; Campbell AV
    Cell Stem Cell; 2011 Nov; 9(5):393-6. PubMed ID: 22056136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risky business.
    Westphal SP
    New Sci; 2003 Jul; 179(2404):24. PubMed ID: 14686416
    [No Abstract]   [Full Text] [Related]  

  • 19. FDA scrutinizes human stem cell therapies.
    Fox JL
    Nat Biotechnol; 2008 Jun; 26(6):598-9. PubMed ID: 18536668
    [No Abstract]   [Full Text] [Related]  

  • 20. Treating diseases with adult stem cells.
    Prentice DA; Tarne G
    Science; 2007 Jan; 315(5810):328. PubMed ID: 17234930
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.